How drugs act. 25. Biological drugs and vaccines
Smith, S.E.
Nursing Times 71(50): 1992-1993
1975
ISSN/ISBN: 0954-7762 PMID: 1196995 Document Number: 90722
Document emailed within 1 workday
Related Documents
1999: Drugs and vaccines against biological weapons Medical Letter on Drugs and Therapeutics 41(1046): 15-16Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826
Ennet, D.; Hauschild, J.; Pank, F. 1978: Residues of plant protection products and agents for controlling biological processes in drugs of the pharmacopoeia of the GDR, edition 2. 1. General aspects of packaging of plant protection products and agents for controlling biological processes in botanical drugs in the GDR Die Pharmazie 33(11): 697-705
Marek, J. 1985: On the non-specific antiinflammatory effects of other-than-antirheumatic drugs. Psychotropic drugs, inflammation and antiinflammatory drugs International Journal of Tissue Reactions 7(6): 475-504
Kim, K-Sun. 2019: Current Challenges in the Development of Vaccines and Drugs Against Emerging Vector-borne Diseases Current Medicinal Chemistry 26(16): 2974-2986
Nishikawa, M.; Shirakawa, S.; Hidaka, H. 1987: Non-steroidal anti-inflammatory drugs. Suppression of biological response and non-steroidal anti-inflammatory drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 45(5): 1093-1101
Guerra, I.án.; Bermejo, F. 2015: Biological drugs in inflammatory bowel disease: Management and care Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 107(7): 454
Ammar, H.O.; Ghorab, M.; el-Nahhas, S.A.; Makram, T.S. 1997: Improvement of the biological performance of oral anticoagulant drugs. 2. Dicumarol Die Pharmazie 52(9): 727-728
Takahashi, N.; Ishiguro, N. 2016: Mechanism of action of biological disease--modifying antirheumatic drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 74(6): 882-886
Spangenberg, K.B.; Bødtger, U.; Hansen, K.S.; Chawes, B. 2019: Biological drugs for treatment of children and adolescents with severe asthma Ugeskrift for Laeger 181(6)
Seeling, A.; Wiecha, P.; Oelschläger, H. 2003: Photometric determination of iron contamination of drugs and biological matrices Die Pharmazie 58(5): 312-314
Wong, I.C. 1997: New antiepileptic drugs. Study suggests that under a quarter of patients will still be taking the new drugs after six years Bmj 314(7080): 603-604
Yanaginuma, T. 1984: Clinical pharmacology for midwives. 3. Pregnancy and drugs. 3. Drugs with their risk superseding the benefits Josanpu Zasshi 38(6): 526-530
Degkwitz, R. 1980: Psychotropic drugs. Sense and nonsense in the prescription of sedating, psycholeptic and hypnotic drugs Zfa. Zeitschrift für Allgemeinmedizin 56(2): 77-83
Allen, L.V. 1995: Drugs, devices and delivery considerations in parenteral pharmaceutical care, or, what are they doing with our drugs? PDA Journal of Pharmaceutical Science and Technology 49(6): 306-308
Jacob, J.; Barthelemy, C. 1972: Misuse of drugs and excess of self-administered drugs. Problems posed for the pharmacologist Therapie 27(2): 189-217
Nargeolet, H. 1972: Misuse of drugs and excess of self-administered drugs. Administrative and legislative problems Therapie 27(2): 289-295
Villette, B.; Rybojad, M.; Puissant, A. 1989: Dermatologic manifestation of undesirable effects of drugs (excluding cytostatic drugs) Annales de Medecine Interne 140(7): 609-613
Imai, S. 1975: Action mechanism of anti-hypertensive drugs, with special reference to beta blocking drugs Nihon Jinzo Gakkai Shi 17(7): 674-677